Accera
Company

Last deal

$50M

Amount

Venture - Series Unknown

Stage

04.10.2018

Date

3

all rounds

$196.22M

Total amount

date founded

Financing round

General

About Company
Accera is a biotechnology company that develops therapies for central nervous system disorders, including Alzheimer's disease.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2001

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Accera is focused on discovering and developing therapeutic drugs for neurodegenerative diseases such as Alzheimer's, Parkinson's, and age-associated memory impairment. Their proprietary scientific platform addresses unmet needs in brain health, with a particular focus on Alzheimer's disease. The company's executive management team consists of globally recognized specialists in central nervous system diseases, who leverage the latest scientific knowledge and understanding of neurological disorders. Accera was founded in 2001 and is headquartered in Broomfield, Colorado.
Contacts

Contact Email

Phone number

Social url

Similar Companies
999
Asceneuron

Asceneuron

Asceneuron is a biotech company that develops effective therapeutics for orphan tauopathies and Alzheimer's disease.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Lausanne, Switzerland

total rounds

4

total raised

$130.85M
Athira Pharma

Athira Pharma

Athira Pharma is a drug development company focused on advancing therapies for neurodegenerative diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Pharmaceuticals

Location

Seattle, WA, USA

total rounds

8

total raised

$233.6M
Arbele Corp.

Arbele Corp.

Arbele develops affordable therapeutics for cancer, immune disorders, and neurological diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Seattle, WA, USA
Tetra Therapeutics

Tetra Therapeutics

Tetra Discovery Partners develops drugs for brain-related diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Grand Rapids, MI, USA

total rounds

1

total raised

$5M

Financials

Funding Rounds
7
3

Number of Funding Rounds

$196.22M

Money Raised

Their latest funding was raised on 04.10.2018. Their latest investor POSCO BioVentures. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
26.03.2018
$17.64M
25.10.2013
$69.08M
Wilmar International

Wilmar International

Wilmar International Limited is Asia's leading agribusiness group.

Sector

Food Producers

Subsector

Fruit and Grain Processing

Location

Singapore

total rounds

2

total raised

$200M

count Of Investments

2
Co-Investors
Investors
4
3

Number of lead investors

4

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Series A, Series C, Series D
Yes
Series D
No
Venture - Series Unknown
POSCO BioVentures

POSCO BioVentures

POSCO BioVentures is a VC investing in biotech companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Carlsbad, CA, USA

count Of Investments

13

count Of Exists

3

Bloodstone Ventures

Bloodstone Ventures is a company that was established in 2013.

Sector

General Industrials

Subsector

Diversified Industrials

count Of Investments

1
Inventages Venture Capital Investment Inc.

Inventages Venture Capital Investment Inc.

Inventages Venture Capital Investment Inc is a Nestle SA investment arm that specializes in venture investments.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

London, UK

count Of Investments

33

count Of Exists

5

People

Founders
4
Steve Orndorff
Steve Orndorff

Steve Orndorff

current job

Ariel Pharmaceuticals
Ariel Pharmaceuticals

organization founded

2

Steve Orndorff

Steve A. Orndorff

current job

Accera
Accera

organization founded

1

Steve A. Orndorff

Samuel Henderson
Samuel Henderson

Samuel Henderson

Samuel Henderson's research has defined new pathways in the understanding of neurodegenerative diseases, such as Alzheimer's disease. Most recently, Dr. Henderson was at The Institute of Behavioral Genetics, University of Colorado, Boulder, CO where he investigated the genetics of aging. Prior to that, he was a Lead Scientist at GenoPlex, Inc. directing research in anti-aging technologies. Dr. Henderson has co-authored numerous scientific publications, patents and reviews, including fundamental discoveries in aging research. He received his B.A. in Biology from Washington University, St. Louis, MO and his Ph.D. in Molecular Genetics and Cell Biology from University of Chicago. He received extensive post-doctoral training in developmental biology at the University of Wisconsin. Dr. Henderson is the scientific founder of Accera.

current job

Accera
Accera

organization founded

1

Samuel Henderson

Mark Heiman
Mark Heiman

Mark Heiman

Mark Heiman is CSO at Scioto Biosciences.

current job

Scioto Biosciences
Scioto Biosciences

organization founded

2

Mark Heiman

Employee Profiles
8

Charles Stacey

President and CEO

Thomas Werner

President and CEO

Steve A. Orndorff

Founder

Samuel Henderson

Samuel Henderson

Vice President, Research & Development

Lauren Costantini

Lauren Costantini

VP

William T. Poncy

VO Commercial Development

Holger Kunze

Holger Kunze

President and CEO

Activity

Recent News
0